Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G switches to ACNielsen

This article was originally published in The Tan Sheet

Executive Summary

Consumer products giant will purchase U.S. market share data from ACNielsen effective July 1, firm announces. As a result, P&G will end its relationship with Chicago-based Information Resources, Inc. on June 30. Although financial details of the deal were not disclosed, P&G explained the decision "is a reflection of ACNielsen's commitment to developing a market measurement solution that provides an accurate and comprehensive view of our brands' success in the marketplace." During a recent P&G conference call, firm noted about 50% of U.S. retail sales in categories in which it competes are not tracked by IRI or ACNielsen (1"The Tan Sheet" Nov. 4, 2002, In Brief)...

You may also be interested in...



IRI Buyout Expected To Yield Expanded Client Services, Fund Lawsuit

The sale of market research firm Information Resources, Inc. will result in expanded coverage of the consumer packaged goods industry through improved research technology, President and CEO Joe Durrett said during a June 30 conference call with investors

P&G on market research

About 50% of U.S. retail sales in categories in which P&G competes not tracked by IRI and ACNielsen, CFO Clayton Daley says during Oct. 29 Q1 review. "Our estimates indicate U.S. consumer categories in which we operate are growing about four percentage points faster than the data provided by the main U.S. share data services," he says, adding growth rate differences in P&G businesses have "consistently been even higher." He explains underestimates reflect fact that unmonitored retail channels, including Wal-Mart, club and convenience stores, are growing faster than the food, drug and select mass outlets that are tracked. To compensate, P&G notes it is working with manufacturers and research firms to establish "all-outlet reporting capability" for market measurement...

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094916

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel